Overview

Efficacy of Phentolamine in Prevention of Contrast-Associated Acute Kidney Injury After Complex PCI

Status:
RECRUITING
Trial end date:
2025-01-31
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy and safety of phentolamine in prevention of CA-AKI following complex PCI in patients at high risk of CA-AKI.
Phase:
PHASE2
Details
Lead Sponsor:
Helwan University
Treatments:
Phentolamine